SARS-CoV-2 variant detection and identification by LGC Biosearch Technologies
Place your order directly with the manufacturer.
Status:
Reviewer
Member since: 2020
Organization: University of Karachi
-
- Ease of use
- After sales service
- Value for money
Great product with high quality results
Application Area: Used for qualitative detection of specific SARS-CoV-2 mutations
"Easy to understand the instructions. SARS-CoV-2 Variant ValuPanel™ assays gives highly specific and quality results. Highly recommended"
Review date: 11 Sep 2021 | SARS-CoV-2 Variant ValuPanel™ assays
Status:
Reviewer Member since: 2020
Organization: Pfizer
-
- Ease of use
- After sales service
- Value for money
Great product, easy to use.
Application Area:Development of in house testing (not patient samples)
"The kit was super straightforward and easy to use. All materials fit into the CDC published method for COVID-19 testing. No issues with getting reproducible results."
Review date: 23 Jul 2020 | 2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2
Emerging SARS-CoV-2 variants will require global monitoring to ensure diagnostic tests, vaccines, and other antiviral therapies remain effective. As the virus’ mutations change its transmissibility and/or severity, public health control measures can stay ahead of the curve by analysing a subset of positive COVID-19 patient samples. These genomic surveillance programs include genotyping and sequencing the mutations, which can help characterise known variants and discover novel variants.
Product Overview
SARS-CoV-2 variant detection and identification
Manufacturer LGC Biosearch Technologies | Available Worldwide
4.7 / 5.0 | 2 reviews
